【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Disease overview
• Introduction
• Risk factors
• Diagnosis
• Management
• Epidemiology
• Economic burden
PART 06: Pipeline portfolio
PART 07: Market landscape
• Global diabetes drugs market
• Global type 2 diabetes drugs market
• Five forces analysis
PART 08: Market segmentation by drug class
PART 09: Insulin
• Product portfolio
• Global insulin market
PART 10: DPP-4 inhibitors
• Market overview
• Market size and forecast
PART 11: GLP-1 receptor agonists
• Market overview
• Market size and forecast
PART 12: SGLT-2 inhibitors
• Market overview
• Market size and forecast
PART 13: Geographical segmentation
• Global type 2 diabetes drugs market by geographical segmentation 2015-2020
• Type 2 diabetes drugs market in Americas
• Type 2 diabetes drugs market in EMEA
• Type 2 diabetes drugs market in APAC
PART 14: Market drivers
• Rising prevalence of diabetes
• Rise in obesity rates
• Growing older population
• Unmet medical needs
• Stringent regulatory guidelines for biosimilar drugs
PART 15: Impact of drivers
PART 16: Market challenges
• Low diagnosis rate
• Rising concerns in scientific community
• Gaps in national-level diabetes management plans
• Poor storage conditions and distribution policies for insulin
• Fierce market competition
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Increase in awareness of diabetes
• Increase in academia-industry collaboration
• Rising price of diabetes drugs
• Increase in R&D
PART 19: Vendor landscape
• Competitive scenario
• Market analysis 2015
• Novo Nordisk
• Sanofi
• Merck
• Eli Lilly
• AstraZeneca
• Other prominent vendors
PART 20: Appendix0
• List of abbreviations
PART 21: Explore Technavio1
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for type 2 diabetes drugs
Exhibit 03: Line of therapy for type 2 diabetes
Exhibit 04: Pipeline portfolio: Global type 2 diabetes drugs market
Exhibit 05: Global diabetes drugs market by prevalence based on type of disease 2015
Exhibit 06: Top selling diabetes drugs based on sales 2014 ($ billions)
Exhibit 07: Market share of global diabetes drugs in global pharmaceutical drugs market 2015
Exhibit 08: Global diabetes drugs market 2015-2020 ($ billions)
Exhibit 09: Market share analysis of vendors in global diabetes drugs market
Exhibit 10: Global type 2 diabetes drugs market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Segmentation of global type 2 diabetes drugs market by drug class
Exhibit 13: Segmentation of global type 2 diabetes drugs market by drug class 2015
Exhibit 14: Comparison of different classes of type 2 diabetes drugs
Exhibit 15: Global human insulin market 2015-2020 ($ billions)
Exhibit 16: Global insulin market revenues by type of diabetes 2015
Exhibit 17: Segmentation of global insulin market based by drug class 2015
Exhibit 18: Segmentation of global insulin market by geography 2015
Exhibit 19: DPP-4 inhibitor drugs approved in market
Exhibit 20: Global DPP-4 inhibitors drugs market for type 2 diabetes 2015-2020 ($ billions)
Exhibit 21: GLP-1 receptor agonists approved in market
Exhibit 22: Global GLP-1 receptor agonists drugs market for type 2 diabetes 2015-2020 ($ billions)
Exhibit 23: Segmentation of global GLP-1 receptor agonists drugs market for type 2 diabetes by geography 2015
Exhibit 24: Approved SGLT-2 inhibitor drugs
Exhibit 25: Global SGLT-2 inhibitors market for type 2 diabetes 2015-2020 ($ billions)
Exhibit 26: Segmentation of global type 2 diabetes drugs market by geography 2015
Exhibit 27: Global type 2 diabetes drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 28: Percentage share of global type 2 diabetes drugs market by geography 2015-2020
Exhibit 29: Type 2 diabetes drugs market in Americas 2015-2020 ($ billions)
Exhibit 30: Segmentation of type 2 diabetes drugs market in Americas by country 2015
Exhibit 31: Type 2 diabetes drugs market in US 2015-2020 ($ billions)
Exhibit 32: Type 2 diabetes drugs market in Brazil 2015-2020 ($ billions)
Exhibit 33: Type 2 diabetes drugs market in EMEA 2015-2020 ($ billions)
Exhibit 34: Type 2 diabetes drugs market in APAC 2015-2020 ($ billions)
Exhibit 35: Segmentation of type 2 diabetes drugs market in APAC by country 2015
Exhibit 36: Global type 2 diabetes drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 37: Impact of drivers
Exhibit 38: Impact of drivers and challenges
Exhibit 39: YOY revenues from sales of top seven products in global type 2 diabetes drugs market 2012-2014 ($ billions)
Exhibit 40: Novo Nordisk: Business segmentation by revenue 2015
Exhibit 41: Novo Nordisk: R&D expenditure 2015
Exhibit 42: Novo Nordisk: Key product offerings in global type 2 diabetes drugs market
Exhibit 43: Novo Nordisk: YoY revenue and growth rate generated from net product sales of human insulins 2012-2015 ($ billions)
Exhibit 44: Novo Nordisk: YoY revenue and growth rate generated from net product sales of Levemir 2012-2015 ($ billions)
Exhibit 45: Novo Nordisk: YoY revenue and growth rate of NovoRapid/NovoLog 2012-2015 ($ billions)
Exhibit 46: Novo Nordisk: Revenues of NovoRapid/NovoLog by geography 2015
Exhibit 47: Novo Nordisk: YoY revenue and growth rate of NovoMix/NovoLog Mix 2012-2015 ($ billions)
Exhibit 48: Novo Nordisk: Revenues of NovoMix/NovoLog Mix by geography 2015
Exhibit 49: Novo Nordisk: YOY revenue and growth rate generated from net product sales of new-generation insulins 2013-2015 ($ millions)
Exhibit 50: Novo Nordisk: YoY revenue and growth rate of Victoza 2012-2015 ($ billions)
Exhibit 51: Novo Nordisk: YoY revenue and growth rate of Victoza in US 2013-2015 ($ billions)
Exhibit 52: Novo Nordisk: YoY revenue and growth rate of Victoza in Europe 2013-2015 ($ billions)
Exhibit 53: Novo Nordisk: YoY revenue and growth rate of Novonorm, Prandin, and Prandimet 2012-2014 ($ billions)
Exhibit 54: Novo Nordisk: Key takeaways
Exhibit 55: Sanofi: Business segmentation by revenue 2015
Exhibit 56: Sanofi: Key product offerings in global type 2 diabetes drugs market
Exhibit 57: Sanofi: YoY revenue and growth rate of Lantus 2012-2015 ($ billions)
Exhibit 58: Sanofi: Geographical segmentation of Lantus by revenue 2015
Exhibit 59: Sanofi: YoY revenue and growth rate of Amaryl 2012-2015 ($ millions)
Exhibit 60: Sanofi: Geographical segmentation of Amaryl by revenue 2015
Exhibit 61: Sanofi: YoY revenue and growth rate of Apidra 2012-2015 ($ millions)
Exhibit 62: Sanofi: Geographical segmentation of Toujeo by revenue 2015
Exhibit 63: Sanofi: YoY revenue and growth rate of Insuman 2012-2015 ($ millions)
Exhibit 64: Sanofi: YoY revenue and growth rate of Lyxumia 2013-2015 ($ millions)
Exhibit 65: Sanofi: Key takeaways
Exhibit 66: Merck: Business segmentation by revenue 2015
Exhibit 67: Merck: Diabetes segmentation by revenue 2015
Exhibit 68: Merck: Key product offerings in global type 2 diabetes drugs market
Exhibit 69: Merck: YoY revenue and growth rate of Janumet 2012-2015 ($ billions)
Exhibit 70: Merck: YoY revenue and growth rate of Januvia from 2012-2015 ($ billions)
Exhibit 71: Merck: Key takeaways0
Exhibit 72: Eli Lilly: Key product offerings in global type 2 diabetes drugs market1
Exhibit 73: Eli Lilly: YoY revenue and growth rate of Humalog 2012-2015 ($ billions)1
Exhibit 74: Eli Lilly: YoY revenue and growth rate of Humalog in US 2013-2015 ($ billions)2
Exhibit 75: Eli Lilly: YoY revenue and growth rate of Humalog in ROW 2013-2015 ($ billions)2
Exhibit 76: Eli Lilly: YoY revenue and growth rate of Humulin 2012-2015 ($ billions)3
Exhibit 77: Eli Lilly: YoY revenue and growth rate of Humulin in US 2013-2015 ($ millions)3
Exhibit 78: Eli Lilly: YoY revenue and growth rate of Humulin in ROW 2013-2015 ($ millions)3
Exhibit 79: Eli Lilly: YoY revenue and growth rate of Tradjenta 2012-2015 ($ millions)4
Exhibit 80: Eli Lilly: YoY revenue of Trulicity 2014-2015 ($ millions)5
Exhibit 81: Eli Lilly: Trulicity geographical segmentation by revenue 20155
Exhibit 82: Eli Lilly: Key takeaways7
Exhibit 83: AstraZeneca: Key product offerings in global type 2 diabetes drugs market9
Exhibit 84: AstraZeneca: Farxiga/Forxiga geographical segmentation by revenues 20159
Exhibit 85: AstraZeneca: YoY revenues and growth rate of Byetta 2012-2015 ($ millions)0
Exhibit 86: AstraZeneca: YoY revenues and growth rate of Byetta in US ($ millions)0
Exhibit 87: AstraZeneca: YoY revenues and growth rate of Bydureon 2012-2015 ($ millions)1
Exhibit 88: AstraZeneca: YoY revenues and growth rate of Bydureon in US ($ millions)1
Exhibit 89: AstraZeneca: YoY revenues and growth rate of Onglyza 2012-2015 ($ millions)2
Exhibit 90: AstraZeneca: YoY revenues and growth rate of Onglyza/Kombiglyze XR/Komboglyze in US ($ millions)2
Exhibit 91: AstraZeneca: Key takeaways
【レポート販売概要】
■ タイトル：2型糖尿病治療薬の世界市場：インスリン、DPP-4阻害薬、GLP-1受容体作動薬、 SGLT-2阻害薬■ 英文：Global Type 2 Diabetes Market 2016-2020
■ 発行日：2016年3月23日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8779
■ 調査対象地域：世界
- Imperial Oil Limited：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Imperial Oil Limited Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Imperial Oil Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- ERP（企業資源計画）のグローバル市場動向（2014-2018）About ERP ERP software is a business management solution that enables organizations to integrate all business operations, including product planning, product development, manufacturing processes, inventory control, and distribution for optimal management. Various modules of ERP software can be purchased as a stand-alone offering or as an embedded offering. Each of these modules pertain to one of t …
- The Kansai Electric Power Company, Inc.：発電所及びSWOT分析2013The Kansai Electric Power Company, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (asse …
- QSFPモジュールの世界市場2017-2021About QSFP Module Market QSFP is an optical transceiver module used in optical fiber communication systems. The main function of this module is photoelectric conversion. In an optical fiber communication system, the information is sent in the form of light pulses, which is then converted into electrical signals in order to be utilized by an electronic device. Technavio’s analysts forecast the Glob …
- マントル細胞リンパ腫治療法の世界市場：併用療法、単独療法Global Mantle Cell Lymphoma Therapeutics Market: About this market Mantle cell lymphoma therapeutics are available in combination therapy and monotherapy. Technavio’s mantle cell lymphoma therapeutics market analysis considers sales from the combination therapy and monotherapy segments. Our analysis also considers the sales of mantle cell lymphoma therapeutics in Asia, Europe, North America, and R …
- 機能性粉末の世界市場：原材料別（大豆、小麦、米、トウモロコシ、豆類、その他）、種類別（特殊粉、調理済み粉末）、製品物（添加物含有粉末、遺伝子組み換え粉末）、用途別（ベーカリー製品、スープ ・ソース、ヌードル・パスタ、レディトゥイート製品）、地域別予測Global Functional Flours Probe Market to reach USD 91.22 billion by 2025. Global Functional Flours Probe Market valued approximately USD 48.22 billion in 2016 is forecasted to grow with a healthy growth rate of more than 7.34% over the forecast period 2018-2025. The major factors speculated to augment the markets are increasing trade of the functional flour and escalating consumer spending along w …
- ConvaTec Inc.：市場シェア分析ConvaTec Inc. Market Share Analysis Summary GlobalData’s new report, “ConvaTec Inc. Market Share Analysis” provides in-depth information on ConvaTec Inc.’s market position in the different medical equipment markets it operates in. The report provides ConvaTec Inc. market share information in two key market categories – Ostomy Drainage Bags and Advanced Wound Management. The report also provides da …
- マグネシウム及びマグネシウム化合物の世界市場動向2014/2015The report presents a thorough study of magnesium and compounds, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing magnesium and compounds worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: magnesium and compo …
- サービスとしての自動化の世界市場：構成要素別（ソリューション＆サービス）、ビジネス機能別（情報技術、販売＆マーケティング、オペレーション、財務、人事、その他）、企業規模別（大企業、中小企業）、業種別（BFSI、テレコム＆IT、小売、ヘルスケア、製造、政府＆防衛、エネルギー＆ユーティリティ、メディア＆エンターテイメント、輸送＆物流、その他）Automation as a Service (AaaS) is a set of disruptive technologies that provide professional services to industries that are willing to adopt automation in their day-to-day processes. Plethora of software applications and rise in need to automate certain processes with redundant responses is a major factor that drives the growth of the market among major social networking players. For instance, in …
- 砕石器の世界市場2016-2020：ESWL、体内砕石器About Lithotripters Lithotripter is a non-invasive device that helps in breaking the kidney stones by passing electromagnetic shock waves from outside the body. The device provides a non-surgical method of destroying/pulverizing stones into small pieces that are capable enough to excrete naturally through individual's urine. Very few lithotripsies are performed through MI procedures that expose in …
- Fluorosilicic Acidの世界市場Fluorosilicic Acid (CAS 16961-83-4) Market Research Report 2013 presents comprehensive data on fluorosilicic acid markets globally and regionally (Europe, Asia, North America etc.) The report includes fluorosilicic acid description, covers its application areas and related patterns. It overviews fluorosilicic acid market, names fluorosilicic acid producers and indicates its suppliers. Besides, the …
- 局所薬物デリバリーの世界市場予測（～2024年）“The topical drug delivery market is projected to grow at a CAGR of 5.7% during the forecast period (2019–2024).”The topical drug delivery market is projected to reach USD 123.2 billion by 2024 from USD 93.2 billion in 2019, at a CAGR of 5.7%. The growth of the topical drug delivery market is driven mainly by the high prevalence of skin disease, rising incidences of eye diseases, high incidence of …
- 水中ロボットの世界市場2015-2019About Underwater Robotics Underwater robots are used for continuous oceanic surveillance. They are designed to work in challenging environments where the safety and accessibility of divers is compromised. Underwater robots have several applications in the fields of maritime security, underwater archaeology, and marine biology. They also play an important role in the development of the Offshore ind …
- グローバルスキンケア製品市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global skincare market throughout the month. Additionally, the report provides an overview of all the partneri …
- 世界の液体ポンプおよび液体エレベーター市場（～2019）The expansion of the global liquid pump and elevator industry is forecast to reach 3.5% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 6.1%. Currently, pumps dispensing lubricants and fuel in filling stations account for 1.1% of the global demand while the remaining market share is divided between other pumps fitted with a measuring device (1. …
